Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03796117
Other study ID # 3.064.351
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 8, 2019
Est. completion date August 30, 2019

Study information

Verified date June 2021
Source Federal University of Rio Grande do Sul
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low frequency pulsed current (PC) and medium frequency alternating current (Russian current - RC, 2.5 kHz) have been largely studied due to their clinical use. However, it is not clear which current is the most efficient due to the existente literature conflicts.Therefore, the purpose of this study is to compare the neuromuscular efficiency, evoked torque, current intensity, fatigability and level of discomfort between the PC and the RC in healthy young. The current types will be tested in the same participant by the intervention sequences randomization. On the first, second, third and fourth days, the maximum voluntary isometric contraction (MVIC), the current intensity level, discomfort level, evoked torque, and clinical and neuromuscular efficiency of each current will be evaluated. Anthropometric measurements will also be assessed on the first day. In addition, the current intensity required to produce a torque level of 20% of the MVIC, the current intensity required to generate a torque of 40 Nm and the maximum intensity tolerated by the participant will be evaluated. Three contractions will be recorded in each condition, and the level of discomfort will be assessed during the evoked contractions. Evoked torque will be evaluated at the maximum tolerated intensity level using the isokinetic dynamometer. Clinical and neuromuscular efficiency will be evaluated (1) at the current intensity necessary to evoke 20% MVIC, (2) at the current intensity necessary to generate 40 Nm, and (3) at the maximum tolerated current intensity. On the fifth and sixth days, muscle fatigue induced by the diferente current types will be evaluated. Fatigue will be evaluated with sufficient current intensity to generate 20% of the MVIC. MVIC will be performed before and after the fatigue protocol, and the fatigue will be determined by the relative variation of the MVIC before and after the fatigue protocol. Fatigue will also be evaluated through the evoked torque variation between the first and the last minute of the fatigue protocol, as well as by the total work generated in each protocol. Neuromuscular efficiency will be evaluated before and immediately after the protocol through (1) the ratio between input NMES current intensity and output evoked torque, (2) total work (area under the evoked force by time curves) generated during the fatigue protocol, and (3) by the changes in muscle architecture from rest to evoked contraction at the maximal current intensity.


Description:

This study is characterized by a quantitative approach, with a randomized crossover clinical study design, blinded to evaluators and participants. The objective is to compare the neuromuscular and clinical efficiency, evoked torque, current intensity, fatigue and discomfort level between the low frequency biphasic pulsed current (PC) and the median frequency sinusoidal alternating Russian current (RC) in healthy young participants. The effect of the two neuromuscular electrical stimulation (NMES) current types on the cited variables will be evaluated in the same participant, by means of the randomization of the interventions sequences for each participant. The evaluation protocols will be performed by 2 blinded raters for the current type and for the outcome variables. A blinded evaluator to the study will randomize the current type, which will be applied on the different evaluation days, through a lottery using opaque envelopes. A researcher blinded to the study groups will analyze the data. Participants will be blinded to the current type will be receiving. The evaluations will be performed in six days, and a minimum interval of 7 days will be observed between the evaluation days. On the first, second, third and fourth days, characterized as Stage 1, the currents' intensity levels, discomfort level, evoked torque, and neuromuscular and clinical efficiency of each randomized current will be evaluated. On the fifth and sixth days, characterized as Stage 2, the muscle fatigue level induced by the two electrical currents will be evaluated. The first evaluation day will be divided into two phases. Phase 1 corresponds to the initial evaluation, anthropometric data collection and physical activity level evaluation. In Phase 2, the quadriceps femoris motor point will be located with a pen-shaped electrode and a neuromuscular electrical stimulation unit, and the subcutaneous adipose layer thickness covering the motor point will be evaluated by means of ultrasonography. Subsequently, the ultrasound probe will be maintained on the vastus lateralis muscle (VL) to obtain muscle architecture data at rest, during the maximal voluntary isometric contractions (MVICs) and during the evoked contractions. Next, a warming up protocol will be performed and the participants will perform three MVICs at the knee joint angles of 60° and 90° of knee flexion (0° = full knee extension) on the isokinetic dynamometer. Subsequently, the investigators will evaluate (1) the current intensity required to produce a torque equivalent to 20% MVIC, (2) the current intensity required to produce a 40 Nm torque, the maximum current intensity (mA) tolerated by the subject (3) at an angle of 60° of knee flexion, and (4) at 90° of knee flexion. From these evaluations, the investigators will analyze the neuromuscular efficiency (ratio between current intensity and evoked torque). After each NMES test, participants will indicate, on the visual-analog scale, the discomfort level perceived with each NMES current type. Clinical efficiency will be evaluated by the ratio between the discomfort level and the evoked torque in the above-described situations. On the second, third and fourth evaluation day, participants will perform all the evaluations described in Phase 2 of the first evaluation day, but with different configurations of the type of current randomized being applied. On the fifth day, the fatigue protocol will be applied with appropriated parameters according to the randomized current type, and sufficient current intensity to generate 20% of the MVIC. The discomfort level during the fatigue protocol will be recorded immediately after the end of the fatigue test. Participants will conduct three pre- and post-fatigue protocol MVICs in order to assess the fatigue level. For the sixth evaluation day, the same evaluations reported for the fifth day will be carried out, but with the second randomized current.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Young male - Age between 18 and 35 years - Physically active, - Normal knee function and range of motion - No pain complaints - No presence of lower limb pathology at the dominant limb. Exclusion Criteria: - Health problems (neurological, musculoskeletal impairment), - Contraindication to maximal exercise, - Having been treated with NMES in the last 3 months in the lower limb - Not meeting the inclusion criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Pulsed current
For stage 1 of the study, which corresponds to analysis of the evoked torque, evaluation of the discomfort level, current intensity, analysis of neuromuscular efficiency and clinical efficiency, 2 configurations (PC1 and PC2) will be used. PC1, will be set at a frequency of 100 Hz, phase duration of 1000 microseconds, ON-OFF time of 5s:10s. PC2, will be set at a frequency of 100 Hz, phase duration of 200 microseconds ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the PC1 configuration will be used.
Russian Current
For stage 1 of the study, which corresponds to analysis of the evoked torque, discomfort level, current intensity, neuromuscular efficiency and clinical efficiency, 2 configurations (RC1 and RC2) will be used. RC1, will be set to a frequency of 100 Hz, burst duty cycle of 20%, ON-OFF time of 5s:10s. RC2, will be set at a frequency of 100 Hz, burst duty cycle of 50%, ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the RC2 configuration will be used.

Locations

Country Name City State
Brazil Exercise Research Laboratory, School of Physical Education, Federal University of Rio Grande do Sul Porto Alegre Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Rio Grande do Sul

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximum voluntary isometric contraction of the knee extensors is an expression of the muscular strength, and will be evaluated by dynamometry. 14 minutes
Primary Knee extensors evoked torque during the tests at submaximal current intensity levels is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry. During 90 seconds of electrical stimulation
Primary Knee extensors evoked torque during the tests at maximal current intensity levels is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry. During 90 seconds of electrical stimulation
Primary Knee extensors evoked torque during the fatigue protocol is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry. During 20 minutes of electrical stimulation
Primary Muscular architecture during the knee extensors maximum voluntary isometric contraction tests is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography. 14 minutes
Primary Muscular architecture during knee extensors evoked torque tests at submaximal current intensity levels is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography. During 90 seconds of electrical stimulation
Primary Muscular architecture during knee extensors evoked torque tests at maximal current intensity levels is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography. During 90 seconds of electrical stimulation
Primary Muscular architecture during the fatigue protocol is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography. During 20 minutes of electrical stimulation
Primary Discomfort level generated by electrical stimulation during evoked torque tests at submaximal current intensity levels Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively. During 90 seconds of electrical stimulation
Primary Discomfort level generated by electrical stimulation during evoked torque tests at maximal current intensity levels Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively. During 90 seconds of electrical stimulation
Primary Discomfort level generated by electrical stimulation during the fatigue protocol Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively. During 20 minutes of electrical stimulation
Primary Current intensity required to evoke knee extensors submaximal torque Current intensity is defined as the amount or amplitude of electrical current (in milliamperes - mA) required to achieve a specific force, and will be evaluated in the electrical stimulation device. During 90 seconds of electrical stimulation
Primary Current intensity required to evoke knee extensors maximal torque Current intensity is defined as the amount or amplitude of electrical current (in milliamperes - mA) required to achieve a specific force, and will be evaluated in the electrical stimulation device. During 90 seconds of electrical stimulation
Primary Neuromuscular efficiency during knee extensors submaximal evoked torque tests Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio. During 90 seconds of electrical stimulation
Primary Neuromuscular efficiency during knee extensors maximal evoked torque tests Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio. During 90 seconds of electrical stimulation
Primary Neuromuscular efficiency during the fatigue protocol Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio. During 20 minutes of electrical stimulation
Primary Clinical efficiency during knee extensors submaximal evoked torque tests Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated. During 90 seconds of electrical stimulation
Primary Clinical efficiency during knee extensors maximal evoked torque tests Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated. During 90 seconds of electrical stimulation
Primary Clinical efficiency during the fatigue protocol Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated. During 20 minutes of electrical stimulation
Primary Muscle Fatigue Index Characterized by the force decrease after the fatigue protocol, it will be evaluated by dynamometry. During 20 minutes of electrical stimulation
Primary Fatigue Index from Evoked Torque Characterized by the decrease of the evoked torque during the fatigue protocol, the fatigue index from evoked torque will be evaluated by dynamometry, and obtained by the analysis of evoked torque curves. During 20 minutes of electrical stimulation
Primary Total work generated during the fatigue protocol The torque-time integral of the evoked torque curves during the fatigue protocol will be evaluated. The sum of the torque curve integral of all evoked contractions during the fatigue protocol will be calculated to determine the total work evoked by each current during the fatigue protocol. During 20 minutes of electrical stimulation
Secondary Thickness of the subcutaneous fat layer on the motor point Corresponds to the amount of subcutaneous adipose tissue and will be evaluated by ultrasonography. It will be evaluated during the first evaluation day.
Secondary Level of physical activity The level of physical activity (PA) of each subject will be assessed by the International Physical Activity Questionnaire (IPAQ).The scores will be assessed by calculating the metabolic equivalents (MET) for each activity level. Walking score will be achieved by the multiplication of 3.3 METs with the total walking duration in minutes in a week. Moderate physical activity scores will be achieved by the multiplication of 4.0 METs with the total moderate physical activity duration in minutes in a week. Vigorous physical activity scores will be achieved by the multiplication of 8.0 METs with the total vigorous physical activity duration in minutes in a week. Total physical activity MET-minutes/week will be obtained through sum of walking, moderate and vigorous MET minutes/week scores. Categorical Score will be classified into three levels of physical activity: low, moderate and high. 8 minutes. It will be evaluated during the first evaluation day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04159012 - NESBID: Neuro-Stimulation of the Brain in Depression N/A
Completed NCT03753581 - Effectiveness of Microcurrents Therapy in Pressure Ulcers in Elderly People N/A
Recruiting NCT05968274 - The Effect of Rebox Current in Pain Management Phase 4
Recruiting NCT04914975 - The Effect of NMES on Bowel Management in People With Chronic SCI N/A
Recruiting NCT05971030 - Clinical Exploratory Research of Medial Prefrontal Cortex Combined With Dorsolateral Prefrontal Cortex Electrical Stimulation in the Treatment of Alzheimer's Disease N/A
Completed NCT02406339 - Effectiveness of NMES Associated to Vascular Occlusion in Functional Performance and Muscle Hypertrophy in Athlete's N/A
Recruiting NCT00739362 - Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment Phase 2
Completed NCT03467087 - Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy N/A
Active, not recruiting NCT04276077 - Electrical Muscle Stimulation on Muscle Stiffness and Functional Capacity in Post-menopausal Women N/A
Completed NCT03319095 - Intravaginal Electrical Nerve Stimulation in Women With Non-contracting Pelvic Floor N/A
Recruiting NCT04036630 - Enhancing Speech Intelligibility Using Transcranial Alternating Current Stimulation (tACS) N/A
Completed NCT03151889 - Eletric Stimulation for Hipossalivation Induced by Radiotherapy N/A
Completed NCT04076878 - Effects of Using the Electrodress Mollii on Spasticity N/A
Active, not recruiting NCT01162993 - Effect of Spinal Cord Stimulation (SCS) in Painful Diabetic Polyneuropathy N/A